Clinical Trials Browser

Phase 1/2 × Withdrawn × Blood Component Removal × Clear all

NCT03100877 2017-12-13

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Phase 1/2 Withdrawn

Multiple Myeloma